EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Identification of a Potential TNF-Alpha Binder Using a Structural Similarity: A Potential Drug Repurposing Approach to the Management of Alzheimer’s Disease

Edward Jenner Tettevi iD, Deryl Nii Okantey Kuevi iD, Balagra Kasim Sumabe iD, David Larbi Simpong iD, Mahmoud B Maina iD, Julius T Dongdem iD, Mike Y Osei-Atweneboana iD, Augustine Ocloo iD

BioMed Research International · 2024

DOI: 10.1155/2024/9985719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, 2024. Verfasst von Edward Jenner Tettevi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Cell and Molecular Biology, School of Biological Science, University of Ghana, Legon, Accra, P.O. Box LG 25, Ghana. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Alzheimer’s disease (AD) is a neurodegenerative disorder with no conclusive remedy. Yohimbine, found in Rauwolfia vomitoria, may reduce brain inflammation by targeting tumour necrosis factor-alpha (TNFα), implicated in AD pathogenesis. Metoserpate, a synthetic compound, may inhibit TNFα. The study is aimed at assessing the potential utility of repurposing metoserpate for TNFα inhibition to reduce neuronal damage and inflammation in AD. The development of safe and effective treatments for AD is crucial to address the growing burden of the disease, which is projected to double over the next two decades.

Methods

Our study repurposed an FDA-approved drug as TNFα inhibitor for AD management using structural similarity studies, molecular docking, and molecular dynamics simulations. Yohimbine was used as a reference compound. Molecular docking used SeeSAR, and molecular dynamics simulation used GROMACS.

Results

Metoserpate was selected from 10 compounds similar to yohimbine based on pharmacokinetic properties and FDA approval status. Molecular docking and simulation studies showed a stable interaction between metoserpate and TNFα over 100 ns (100000 ps). This suggests a reliable and robust interaction between the protein and ligand, supporting the potential utility of repurposing metoserpate for TNFα inhibition in AD treatment.

Conclusion

Our study has identified metoserpate, a previously FDA-approved antihypertensive agent, as a promising candidate for inhibiting TNFα in the management of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansMolecular Docking SimulationTumor Necrosis Factor-alphaDrug RepositioningMolecular Dynamics SimulationYohimbine

Substanzen

Tumor Necrosis Factor-alphaYohimbine

Autor:innen und Institutionen

  • Department of Biochemistry, Cell and Molecular Biology, School of Biological Science, University of Ghana, Legon, Accra, P.O. Box LG 25, Ghana.
  • West African Centre for Cell Biology of Infectious Pathogens, School of Biological Science, University of Ghana, Legon, Accra, P.O. Box LG 25, Ghana.
  • Biomedical and Public Health Research Unit, Council for Scientific and Industrial Research-Water Research Institute, Accra, P.O. Box M 32, Ghana.
  • Department of Medical Laboratory Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana.
  • Serpell Laboratory, Sussex Neuroscience, School of Life Sciences, University of Sussex, UK.
  • Biomedical Science Research and Training Centre, College of Medical Sciences, Yobe State University, Damaturu, Nigeria.

ORCID-Profile: Edward Jenner Tettevi, Deryl Nii Okantey Kuevi, Balagra Kasim Sumabe, David Larbi Simpong, Mahmoud B Maina, Julius T Dongdem, Mike Y Osei-Atweneboana, Augustine Ocloo

Zitieren

APA

Tettevi, E. J., Kuevi, D. N. O., Sumabe, B. K., Simpong, D. L., Maina, M. B., Dongdem, J. T., Osei-Atweneboana, M. Y., & Ocloo, A. (2024). In Silico Identification of a Potential TNF-Alpha Binder Using a Structural Similarity: A Potential Drug Repurposing Approach to the Management of Alzheimer’s Disease. BioMed Research International. https://doi.org/10.1155/2024/9985719

Vancouver

Tettevi EJ, Kuevi DNO, Sumabe BK, Simpong DL, Maina MB, Dongdem JT, et al. In Silico Identification of a Potential TNF-Alpha Binder Using a Structural Similarity: A Potential Drug Repurposing Approach to the Management of Alzheimer’s Disease. BioMed Research International. 2024. doi:10.1155/2024/9985719

BibTeX
@article{Tettevi2024,
  author = {Tettevi, Edward Jenner and Kuevi, Deryl Nii Okantey and Sumabe, Balagra Kasim and Simpong, David Larbi and Maina, Mahmoud B and Dongdem, Julius T and Osei-Atweneboana, Mike Y and Ocloo, Augustine},
  title = {In Silico Identification of a Potential TNF-Alpha Binder Using a Structural Similarity: A Potential Drug Repurposing Approach to the Management of Alzheimer’s Disease},
  journal = {BioMed Research International},
  year = {2024},
  doi = {10.1155/2024/9985719}
}
Kostenlos starten →